Ebenezer Berko
Hematology & Oncology · Alexandria, LANPI 1154366508
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $976 of the $1,109 with a category attached, or 88.1%. It is spread thinly across 20 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $893 and has fallen 96.3% since, to $33 in 2024. That places this record below the midpoint for hematology & oncology clinicians in LA, where the typical reported total is $4,451.
Across 59 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$170
- Bayer$160
- E.r. Squibb & Sons, L.L.C.$134
- Novartis$127
- Astellas Pharma US Inc$100
- Amgen$57
- plus $361 from 14 others
Across 25 payments — averaging $894.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$15K
- E.r. Squibb & Sons, L.L.C.$8K
What the payments were for
- Food & beverage$97688%
- Education$13212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $170 |
| Bayer | 3 | $160 |
| E.r. Squibb & Sons, L.L.C. | 10 | $134 |
| Novartis | 9 | $127 |
| Astellas Pharma US Inc | 1 | $100 |
| Amgen | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Tesaro, Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Karyopharm Therapeutics Inc. | 2 | $34 |
| Pharmacosmos Therapeutics Inc. | 1 | $33 |
| AstraZeneca | 2 | $31 |
| Pfizer | 2 | $28 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Array Biopharma Inc | 1 | $17 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Partner Therapeutics, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Clovis Oncology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xofigo$125
How this compares
$1,109 in reported general payments places this provider in the 20th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in Alexandria
- Hafez HalawaniAlexandria$18K
- Bassam Abi-RachedAlexandria$13K
- Hana SafahBaton Rouge$2M
- Pedro BarataNew Orleans$928K
- Maissaa JanbainNew Orleans$862K
- Nakhle SabaBaton Rouge$842K
- Marc MatranaNew Orleans$757K
- Prakash PeddiShreveport$405K
- Sanjay JunejaBaton Rouge$346K
- Lingling duNew Orleans$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.